Previous Close | 42.95 |
Open | 43.49 |
Bid | 45.00 x N/A |
Ask | 46.00 x N/A |
Day's Range | 43.00 - 48.00 |
52 Week Range | 6.50 - 48.00 |
Volume | 11,936,007 |
Avg. Volume | 3,183,755 |
Market Cap | 301.231M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.20 |
Earnings Date | Jun 21, 2021 - Jun 25, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
If you want to know who really controls Open Orphan plc ( LON:ORPH ), then you'll have to look at the makeup of its...
Federal government increasing state allotment of vaccines. Meanwhile, U.K. begins first human challenge trials.
Open Orphan (AIM:ORPH) announced the world’s first COVID-19 characterization study has received ethics approval in the UK.